“…Studies comparing nebulized vs. intratracheal surfactant and powered to examine not only respiratory outcomes but morbidities of prematurity such as mortality, chronic lung disease, retinopathy of prematurity, intraventircular hemorrhage and necrotizing enterocolitis are required to further evaluate nebulized efficacy. Since Marshall et al [25] reported transient desaturation episodes with administration, a long-term study of neurodevelopmental outcome should also be considered. To date, the only surfactant preparation with sufficient data to report retention of biological activity after nebulization is lucinactant-a synthetic preparation consisting of DPPC, palmitoyleleoyl, phosphatidyl glycerol, palmitic acid and KL4, a novel synthetic peptide similar to surfactant protein B.…”